Specifically, DNA-PKcs has been shown to promote sarcomagenesis (122) and to sustain the activity of c-Myc (123) and AKTs (124), which are known to foster radioresistance in ERMS (116, 125–127) and ARMS tumors (128). The gene discussed is PRKDC; the disease is alveolar rhabdomyosarcoma.